Ampligen became the first drug ever approved for use in ME/CFS when ANMAT, Argentine’s FDA, approved the drug for use in severe ME/CFS patients. The approval should provide a clear pathway for Ampligen’s approval elsewhere. The U.S. is the odd man out in this scenario, but the company is making progress here too. Find out how in
Health Rising brings you the latest research and treatment findings on chronic fatigue syndrome (ME/CFS) and fibromyalgia (FM). Funded almost entirely by donors, Health Rising makes a big impact on a small budget. Its 1,600 blogs, pages and resources were visited by over 600,000 people last year. Please keep the information flowing with your recurring (as low as $5/month) or one-time donation. Find out more here.